TMCnet News
Zafgen to Present at the Wedbush PacGrow Healthcare ConferenceBOSTON, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients affected by a range of metabolic diseases, announced today that Jeffrey Hatfield, Chief Executive Officer of Zafgen, Inc. is scheduled to present at the Wedbush PacGrow Healthcare Conference on Tuesday, August 13, 2019, at 8:00 a.m. ET. A live audio webcast and replay of the presentation will be available through the Events and Presentations page of the Investors section of the Company's website (www.zafgen.com About Zafgen Media/Investor Relations Contacts: Media Investors |